Ozempic Cost 2026: Price Without Insurance
Ozempic price breakdown for 2026: monthly cost without insurance, how insurance and savings cards apply, and how Trimi's compounded semaglutide is priced at a flat $99/month.
Written by Trimi Medical Team. Medically reviewed by Dr. Sean Arora, MD. Pricing data is based on current pharmacy surveys, manufacturer information, and market analysis.
Quick links: Semaglutide treatment, tirzepatide treatment, and best GLP-1 provider guide.
More on GLP-1 Provider Comparisons
Ozempic vs Compounded Semaglutide
Cost and effectiveness comparison of Ozempic and compounded options.
Ozempic Alternatives 2026
What to consider when brand-name Ozempic is not accessible.
Wegovy Cost 2026
How Wegovy pricing compares to Ozempic.
Cheapest Semaglutide 2026
Every semaglutide option ranked by price.
Ozempic Pricing in 2026: What You Need to Know
Ozempic (semaglutide) has become one of the most recognized medication names in America, driven by its remarkable effectiveness for both type 2 diabetes and weight loss. Manufactured by Novo Nordisk, Ozempic was FDA-approved in 2017 for diabetes but has become widely prescribed off-label for weight management. Its effectiveness is not in question, but its affordability is a major barrier for millions of patients.
In 2026, Ozempic's retail price without insurance ranges from $900 to $1,100 per month. This price covers a single multi-dose pen providing four weekly injections. Unlike some brand-name GLP-1 medications that come in single-dose pens, Ozempic's multi-dose pen design means you use the same pen for the entire month, dialing to your prescribed dose for each injection.
For patients using Ozempic specifically for weight loss rather than diabetes, the cost picture is particularly challenging. Insurance coverage for off-label use is often denied, meaning patients face the full retail price. This has made compounded semaglutide the practical choice for many patients seeking semaglutide for weight management.
Ozempic Cost by Dose Level
| Dose | Ozempic Retail (Monthly) | Ozempic Retail (Annual) | Notes |
|---|---|---|---|
| 0.25mg weekly | ~$950/mo | ~$11,400/yr | Starting dose (first 4 weeks) |
| 0.5mg weekly | ~$950/mo | ~$11,400/yr | First titration step |
| 1mg weekly | ~$950/mo | ~$11,400/yr | Common maintenance dose |
| 2mg weekly | ~$1,050/mo | ~$12,600/yr | Maximum labeled dose |
Ozempic's retail price is close to flat across dose levels, so patients pay nearly the same amount during the 0.25mg titration month as they do at a 1mg maintenance dose. If you want to see how Trimi's own flat monthly rate is structured and what it includes, our cost guide breaks it down by plan length.
Insurance and Coverage Realities
Understanding insurance coverage for Ozempic requires distinguishing between its two common uses. For type 2 diabetes, its FDA-approved indication, Ozempic generally has better insurance coverage. Most major commercial insurance plans include Ozempic on their formularies for diabetes, though copays, prior authorization requirements, and tier placement vary significantly.
For weight loss, the off-label use that has driven much of Ozempic's popularity, insurance coverage is much more limited. Most insurance plans either deny coverage for off-label weight loss use entirely or impose strict requirements that many patients cannot meet. The irony is that millions of patients have heard about Ozempic through weight loss media coverage, only to discover that accessing it for that purpose at an affordable price through traditional insurance channels is extremely difficult.
Commercial insurance coverage for diabetes use: generally available but with prior auth and copay requirements
Off-label weight loss coverage: frequently denied or heavily restricted
Medicare Part D: coverage varies by plan; many exclude off-label use
High-deductible plans: patients pay full retail until deductible is met
Even with coverage, specialty copays can exceed $200 per month
For patients who need semaglutide for weight loss but lack coverage, compounded semaglutide through Trimi eliminates the insurance middleman entirely. No prior authorization, no coverage denials, no appeals process, just straightforward access to the same medication at a price that works for your budget.
Savings Programs and Their Limits
Novo Nordisk offers an Ozempic savings card that can reduce copays for commercially insured patients. When the savings card works as intended, it can bring copays down to as low as $25 per month, a significant savings. However, the card has substantial limitations that prevent it from being a universal solution.
The savings card requires commercial insurance that covers Ozempic, patients without insurance or with government insurance (Medicare, Medicaid, Tricare) cannot use it. There is a maximum annual benefit amount, after which patients revert to their standard copay. The card also has an expiration date and may not be available indefinitely. For patients who qualify and whose insurance covers Ozempic, the savings card can be valuable. Patients who do not qualify sometimes ask a provider about compounded semaglutide, which is billed as a flat cash-pay rate with no insurance requirement.
Compounded Semaglutide: How Trimi's Pricing Works
Trimi's compounded semaglutide is $99 per month on the annual plan. That is a flat cash-pay rate with no insurance billing, no prior authorization, and no deductible to meet, so the monthly number is predictable from the first month onward. Compounded semaglutide is not FDA-approved, and the FDA does not review compounded drugs for safety, effectiveness, or quality.
Pharmaceutical-grade semaglutide compounded per prescription by a licensed pharmacy
Flat $99 per month on the annual plan, priced the same at every dose level
No insurance required, transparent monthly pricing
Flexible dosing, providers can prescribe exact doses including Wegovy-level 2.4mg
Board-certified providers specializing in weight management
Medication, consultations, medical oversight, and shipping all included
Month-to-month treatment with no long-term contracts
Accredited compounding pharmacy partnerships with quality testing
For a comprehensive look at how to access semaglutide at the lowest possible cost, see our guides on how to get semaglutide cheap and Ozempic alternatives in 2026.
Bottom Line
Ozempic is an exceptional medication, and semaglutide has genuinely changed the landscape of weight management. But at $900 to $1,100 per month without insurance, brand-name Ozempic is not financially sustainable for most patients, especially those using it off-label for weight loss where insurance coverage is limited.
Compounded semaglutide through Trimi is $99 per month on the annual plan, a flat cash-pay rate covering the medication, provider visits, medical oversight, and free overnight shipping once compounded. It is not an FDA-approved product, and whether it is appropriate for you is a decision to make with a licensed provider rather than on price alone.
Frequently Asked Questions
How much does Ozempic cost per month without insurance?
Ozempic's retail price without insurance is approximately $900 to $1,100 per month in 2026, depending on your pharmacy and dose. This price covers a one-month supply of the multi-dose pen. Over a year, patients paying full retail will spend $10,800 to $13,200. Insurance coverage, manufacturer savings cards, and patient assistance programs can change what you actually owe, so confirm current pricing with your pharmacy and plan.
Is Ozempic covered by insurance for weight loss?
Insurance coverage for Ozempic depends on the prescribing indication. When prescribed for its FDA-approved indication of type 2 diabetes, most commercial insurance plans provide coverage, though copays and prior authorization requirements vary. When prescribed off-label for weight loss, coverage is significantly more limited. Many plans deny coverage for off-label use, leaving patients to pay the full retail price. Patients seeking semaglutide specifically for weight loss often end up outside the insurance system entirely and pay cash for whatever their provider prescribes.
Does the Ozempic savings card work for everyone?
No, the Novo Nordisk Ozempic savings card has eligibility requirements that exclude many patients. The card typically requires commercial insurance coverage, meaning patients without insurance, those on Medicare or Medicaid, and those whose plans cover Ozempic with no copay are generally ineligible. Even eligible patients face maximum benefit caps. The savings card can reduce copays for qualifying patients but is not a universal solution for Ozempic affordability.
Why is Ozempic cheaper than Wegovy if they are the same drug?
Ozempic and Wegovy both contain semaglutide, but Wegovy is priced higher because it was specifically developed and FDA-approved for weight management. The higher Wegovy price reflects the additional clinical trials (STEP program) and regulatory process needed for the weight loss indication, as well as market positioning in the obesity treatment space. Ozempic, approved earlier for diabetes, is priced somewhat lower but still well above what most patients can comfortably afford without insurance.
Can I get Ozempic for free through patient assistance?
Novo Nordisk does offer patient assistance programs for eligible uninsured or underinsured patients who meet income requirements. These programs can provide Ozempic at no cost for qualifying individuals. However, the application process can take weeks, eligibility is based on income guidelines, and the programs have limited capacity. Patients who do not qualify for assistance programs sometimes ask a provider about compounded semaglutide, which is dispensed against an individual prescription on a flat cash-pay basis and does not require navigating income-based eligibility requirements.
Is Ozempic worth the cost for weight loss?
Semaglutide, the active ingredient in Ozempic, is among the most effective weight loss medications available. Whether Ozempic specifically is worth the cost depends on your financial situation and insurance coverage. For patients with insurance that covers Ozempic at a reasonable copay, it is an excellent option. For patients paying out of pocket, compounded semaglutide is another route worth raising with a clinician, keeping in mind that compounded drugs are not FDA-approved.
How is compounded semaglutide different from Ozempic?
Ozempic is an FDA-approved brand-name product from Novo Nordisk, reviewed by the FDA for safety, efficacy, and manufacturing quality, and dispensed in a manufacturer-filled multi-dose pen. Compounded semaglutide is prepared by a licensed compounding pharmacy against an individual prescription; it is not FDA-approved, and the FDA does not review compounded drugs for safety or effectiveness. Trimi's compounded semaglutide is offered at a flat $99 per month on the annual plan, which includes provider visits, medical oversight, and shipping. Which route is right for you is a clinical conversation with a licensed provider.
Sources & References
Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Pricing information is based on publicly available data and may vary by pharmacy and location. Always verify current pricing directly with providers. Trimi offers compounded semaglutide, readers should be aware of our perspective.